Overview
Maryam Dastmalchi practices in Solna, Sweden. Ms. Dastmalchi is rated as an Elite expert by MediFind in the treatment of Polymyositis. Her top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Necrotizing Myopathy (NM).
Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles and participated in 1 clinical trial in the study of Polymyositis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- DermatomyositisMs. Dastmalchi isElite. Learn about Dermatomyositis.
- MyositisMs. Dastmalchi isElite. Learn about Myositis.
- PolymyositisMs. Dastmalchi isElite. Learn about Polymyositis.
- Distinguished
- Necrotizing Myopathy (NM)Ms. Dastmalchi isDistinguished. Learn about Necrotizing Myopathy (NM).
- Advanced
- Antisynthetase SyndromeMs. Dastmalchi isAdvanced. Learn about Antisynthetase Syndrome.
- Experienced
- Acute Interstitial PneumoniaMs. Dastmalchi isExperienced. Learn about Acute Interstitial Pneumonia.
- Inclusion Body MyositisMs. Dastmalchi isExperienced. Learn about Inclusion Body Myositis.
- Interstitial Lung DiseaseMs. Dastmalchi isExperienced. Learn about Interstitial Lung Disease.
- NecrosisMs. Dastmalchi isExperienced. Learn about Necrosis.